1
Clinical Trials associated with Diphenhydramine/Dropropizine/PseudoephedrineMulticenter Clinical Trial, Phase III, Controlled, Open, Parallel Group, Randomized, Comparing the Fixed Dose Combination of Diphenhydramine + Dropropizine + Pseudoephedrine and the Combined Use of Dropropizine and Fixed Dose Combination of Pseudoephedrine Hydrochloride + Brompheniramine Maleate Used Orally for Evaluation of Efficacy and Safety in Control Cough and the Relief of Nasal Symptoms in Children 2 to 12 Years Old, Suffering From Non-productive Cough and Acute Rhinitis.
Multicenter clinical trial, phase III, controlled by active medicine, open, randomized, enroll 962 children, 2 to 12 years old, that suffer acute inflammation upper airway characterized by non-productive cough, daytime/nighttime, with duration for at least 3 and no more than 5 consecutive days (without systemic/topic use of medication during this period) followed by nasal congestion, with or without associate other nasal symptoms (sneezing, runny nose, nasal itching and/or mouth breathing). The subjects will be allocated in 2 parallel groups, and will receive the medicines of study, according of the randomization.
100 Clinical Results associated with Diphenhydramine/Dropropizine/Pseudoephedrine
100 Translational Medicine associated with Diphenhydramine/Dropropizine/Pseudoephedrine
100 Patents (Medical) associated with Diphenhydramine/Dropropizine/Pseudoephedrine
100 Deals associated with Diphenhydramine/Dropropizine/Pseudoephedrine